Management of Atopic Dermatitis: Clinical Utility of Ruxolitinib
Shayan Owji,1,2 Stella A Caldas,1,3 Benjamin Ungar1 1Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 2The University of Texas Medical Branch, Galveston, TX, USA; 3George Washington School of Medicine and Health Sciences, Washington, DC, USACorrespondence: Benja...
Main Authors: | Owji S, Caldas SA, Ungar B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-10-01
|
Series: | Journal of Asthma and Allergy |
Subjects: | |
Online Access: | https://www.dovepress.com/management-of-atopic-dermatitis-clinical-utility-of-ruxolitinib-peer-reviewed-fulltext-article-JAA |
Similar Items
-
Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies
by: Eric L. Simpson, et al.
Published: (2024-12-01) -
Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review
by: Yuliya Lytvyn, et al.
Published: (2022-11-01) -
The Psychology of Atopic Dermatitis
by: Ashling Courtney, et al.
Published: (2024-03-01) -
Overview of Atopic Dermatitis in Different Ethnic Groups
by: Andrea Chiricozzi, et al.
Published: (2023-04-01) -
Prevention of Atopic Dermatitis
by: Hywel C. Williams, et al.
Published: (2020-06-01)